One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2018-99-118133
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 12 |
Affiliation: University College London Hospitals NHS Foundation Trust, Emory University, The Christie NHS Foundation Trust, University of Manchester, Humanitas University, Case Western Reserve University, Washington University in St. Louis, Medical College of Wisconsin, Northside Hospital, Adc Therapeutics (Switzerland), Columbia UniversitySafety and Efficacy of Adct-402 (Loncastuximab Tesirine), a Novel Antibody Drug Conjugate, in Relapsed/Refractory Follicular Lymphoma and Mantle Cell Lymphoma: Interim Results from the Phase 1 First-in-Human Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
